Newport Trust Company’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29.7M Sell
696,331
-41,647
-6% -$1.86M 0.07% 46
2026
Q1
$35.6M Sell
737,978
-34,221
-4% -$1.6M 0.09% 46
2025
Q4
$37.4M Buy
+772,199
New +$38.3M 0.09% 45

Other funds holding SNY

Newport Trust Company's SNY Position: Q2 2026 in Review

Newport Trust Company reduced its Sanofi (SNY) stake by 5.6% in Q2 2026, selling an estimated $1.86M and leaving 696,331 shares worth $29.7M. The position accounts for 0.07% of the portfolio, ranked #46.

Newport Trust Company first reported a position in SNY in Q4 2025 and has held it in 3 quarters since. The position peaked at $37.4M in Q4 2025. 718 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Newport Trust Company held 696,331 shares of Sanofi worth $29.7M as of Q2 2026.
  • Newport Trust Company sold 41,647 Sanofi shares in Q2 2026, an estimated $1.86M.
  • Sanofi made up 0.07% of Newport Trust Company's portfolio in Q2 2026, its #46 holding.
  • Newport Trust Company first reported a position in Sanofi in Q4 2025 and has held it in 3 quarters since.
  • Newport Trust Company's Sanofi position peaked at $37.4M in Q4 2025.
  • 718 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Newport Trust Company's 13F filing for Q2 2026, filed 13 Aug 2026.